Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS5116315 A
Publication typeGrant
Application numberUS 07/459,134
Publication dateMay 26, 1992
Filing dateDec 29, 1989
Priority dateOct 3, 1989
Fee statusPaid
Publication number07459134, 459134, US 5116315 A, US 5116315A, US-A-5116315, US5116315 A, US5116315A
InventorsEmil E. Capozzi, H. Stephen Cooksten
Original AssigneeHemaedics, Inc.
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Biological syringe system
US 5116315 A
Abstract
A biological syringe system for delivering a first and second fluid in a mixed composition comprising a manifold. The manifold has first and second component channels therethrough and first and second input connections respectively communicating with the first and second component channels. The first and second component channels terminate in exit channels adjacent to each other on an opposing end of the manifold. A discharge assembly is coupled to the opposing end of the manifold and receives fluid from both of the exit channels. The discharge assembly is used for mixing fluid from both of the exit channels and delivering the mixed fluid in a spray. The discharge assembly has a first and second passage therethrough communicating with the exit channels from the manifold for carrying fluid from the first and second component channels in corresponding first and second passages within the discharge assembly while maintaining the first and second fluids separated from each other. The discharge assembly has a mixing space defined therein to receive separate flows from the passages. The discharge assembly further comprises a mixing mechanism disposed within the mixing space to thoroughly mix the first and second fluids for the first time within the mixing space and to immediately thereafter atomize the thoroughly mixed first and second fluids in a spray discharged from the discharge assembly.
Images(4)
Previous page
Next page
Claims(19)
We claim:
1. A biological syringe system for delivering a first and second fluid in a mixed composition comprising:
a manifold, said manifold having first and second component channels therethrough, said manifold further having first and second input connections respectively communicating with said first and second component channels, said first and second component channels terminating in exit channels adjacent to each other on an opposing end of said manifold;
a discharge assembly coupled to said opposing end of said manifold and receiving fluid from both of said exit channels, said discharge assembly for mixing fluid from both of said exit channels and delivering said mixed fluid in a spray, said discharge assembly having a first and second passage therethrough communicating with said exit channels from said manifold for carrying fluid from said first and second component channels in corresponding first and second passages within said discharge assembly while maintaining said first and second fluids separated from each other, said discharge assembly having a mixing space defined therein to receive separate flows from said passages, said discharge assembly further comprising mixing means disposed within said mixing space to thoroughly mix said first and second fluids for the first time within said mixing space and to immediately thereafter atomize said thoroughly mixed first and second fluids in a spray discharged from said discharge assembly.
2. The biological syringe system of claim 1 wherein said means for thoroughly mixing and atomizing said first and second fluid into a spray comprises a shaped spray nozzle having a spray outlet defined therein, said shaped spray nozzle being disposed within said mixing space.
3. The biological syringe system of claim 2 wherein said first and second passages have outlet ends, and wherein said discharge assembly comprises a solid cylindrical body disposed within said mixing space, said solid cylindrical body having a first end surface adjacent outlet ends of said first and second passage in said discharge assembly, said first and second fluids exiting said outlet ends of said passages and flowing into a cylindrical annular space between said nozzle disposed in said mixing space and said cylindrical body disposed in said mixing space, said first and second fluids mixing for the first time within said cylindrical annular space and flowing to a portion of said mixing space adjacent an opposing end of said solid cylindrical body opposite said spray outlet, said mixed first and second fluids then being expressed through said spray outlet as atomized spray particles.
4. The syringe system of claim 3 comprising means for swirling said first and second fluids together in said mixing space.
5. A biological syringe system for delivering a first and second fluid in a mixed composition comprising:
a manifold, said manifold having first and second component channels therethrough, and further having first and second input connections respectively communicating with said first and second component channels, said first and second component channels terminating in exit channels adjacent to each other on an opposing end of said manifold;
a discharge assembly coupled to said opposing end of said manifold and receiving fluid from both of said exit channels, said discharge assembly for mixing fluid from both of said exit channels and delivering said mixed fluid in a spray, said discharge assembly having a first and second passage therethrough communicating with said exit channels from said manifold for carrying fluid from said first and second component channels in corresponding first and second passages within said discharge assembly while maintaining said first and second fluids separated from each other, said first and second passages having outlets ends, said discharge assembly having a mixing space defined therein to receive separate flows from said passages, said discharge assembly further comprising a shaped spray nozzle having a spray outlet defined therein, said shaped spray nozzle being disposed within said mixing space to thoroughly mix said first and second fluids for the first time within said mixing space and to immediately thereafter atomize said thoroughly mixed first and second fluids in a spray discharged from said discharge assembly; said discharge assembly comprising a solid cylindrical body disposed within said mixing space, said solid cylindrical body having a first end surface adjacent outlet ends of said first and second passage in said discharge assembly, said first and second fluids exiting said outlet ends of said passages and flowing into a cylindrical annular space between said nozzle disposed in said mixing space and said cylindrical body disposed in said mixing space;
swirling means for swirling said first and second fluids together in said mixing space, said first and second fluids mixing for the first time within said cylindrical annular space and flowing to a portion of said mixing space adjacent an opposing end of said solid cylindrical body opposite said spray outlet, said mixed first and second fluids then being expressed through said spray outlet as atomized spray particles; and
a plurality of wedged shaped surfaces azimuthally disposed about said spray outlet, said wedged shaped surfaces being inclined in an azimuthal direction relative to said spray outlet to impel an azimuthal flow to said first and second fluids about said spray outlet.
6. The syringe system of claim 5 wherein a generally radially disposed channel separates each of said wedged shaped surfaces, said channel in combination with an adjacent wedged shaped surface directing flow of said first and second fluid in an azimuthal direction about a predetermined cylindrical space adjacent to and centered about said spray outlet.
7. The syringe system of claim 4 wherein said means spirals said first and second fluids together to thoroughly mix said first and second fluids for the first time immediately prior to ejection through said spray outlet.
8. A method for applying a tissue adhesive and protective covering which chemically forms and hardens as applied comprising the steps of:
providing a first fluid;
providing a second fluid which when mixed with said first fluid hardens into said tissue adhesive;
forcing said first and second fluids from a corresponding first and second syringe into corresponding first and second passages;
partially mixing said first and second fluids together by flowing said fluids under pressure within a cylindrical annular space; and
forcing said partially mixed first and second fluids from said cylindrical annular space into a final mixing chamber;
thoroughly mixing said first and second fluids in said final mixing chamber;
forcing said thoroughly mixed fluids to an axial spray orifice;
atomizing said thoroughly mixed first and second fluids by pressured ejection of said fluids through said spray orifice at a predetermined minimum pressure,
whereby mixture of said first and second fluids is substantially improved, strength and hardening of said tissue adhesive substantially improved, and wherein thorough mixing occurs just prior to application in atomized form.
9. The method of claim 8 wherein said first and second fluids are swirled together as said first and second fluid flows from said outlet ends of said passages through said cylindrical annular space and thence radially inward to an axial spray orifice to thoroughly mix said fluids within a mixing space of predetermined limited volume followed by immediate ejection in atomized form for application and hardening.
10. The method of claim 8 where in said step of thoroughly mixing said first and second fluids, said first and second fluids are spiralled together for the first time just prior to forcing said fluids through said spray outlet.
11. A method for applying a tissue adhesive and protective covering which chemically forms and hardens as applied comprising the steps of:
providing a first fluid;
separately providing a second fluid which when mixed with said first fluid hardens into said tissue adhesive;
maintaining said first and second fluids substantially separate as said fluids are delivered to a mixing chamber;
thoroughly mixing said first and second fluids in said mixing chamber for the first time;
atomizing said thoroughly mixed first and second fluids by pressured ejection of said fluids through a spray orifice at a predetermined minimum pressure, said step of thoroughly mixing being performed immediately before said step of atomizing so that substantially no reaction has occured between said first and second fluids until after said step of atomizing,
whereby mixture of said first and second fluids is substantially improved, strength and hardening of said tissue adhesive substantially improved, and wherein thorough mixing occurs just prior to application in atomized form.
12. The method of claim 11 where said step of thoroughly mixing said first and second fluids comprises the step of swirling said first and second fluids together for the first time in said mixing chamber just prior to atomizing.
13. The method of claim 11 where said step of thoroughly mixing is performed relative to said other steps of said method to minimize the time during which said first and second fluids are being mixed together.
14. The method of claim 13 further comprising the step of uniformly applying said atomized mixture of said first and second fluids to a selected wound site.
15. The method of claim 14 further comprising the step of curing said applied mixture of said first and second fluids to form an artificial tissue surface.
16. The method of claim 15 where said step of curing is performed to minimize the time during which curing of said artificial tissue occurs after said step of atomizing.
17. A method for applying a tissue adhesive and protective covering which chemically forms and hardens as applied comprising the steps of:
providing a first fluid;
providing a second fluid which when mixed with said first fluid hardens into said tissue adhesive;
forcing said first and second fluids from a corresponding first and second syringe into corresponding first and second passages;
partially mixing said first and second fluids together by flowing said fluids under pressure within a cylindrical annular space;
forcing said partially mixed first and second fluids from said cylindrical annular space into a final mixing chamber;
thoroughly mixing said first and second fluids in said final mixing chamber; and
forcing said thoroughly mixed fluids to an axial spray orifice to atomize said thoroughly mixed first and second fluids by pressured ejection of said through said spray orifice at a predetermined minimum pressure,
wherein said step of mixing said first and second fluids are swirled together as said first and second fluid flows from said outlet ends of said passages through said cylindrical annular space and thence radially inward to an axial spray orifice to thoroughly mix said fluids within a mixing space of predetermined limited volume followed by immediate ejection in atomized form for application and hardening,
whereby mixture of said first and second fluids is substantially improved, strength and hardening of said tissue adhesive substantially improved and wherein thorough mixing occurs just prior to application in atomized form.
18. An apparatus for applying a tissue adhesive and protective covering which chemically forms and hardens as applied comprising:
first fluid providing means for providing a first fluid to a mixing area within said apparatus;
second fluid providing means for providing to said mixing area a second fluid which when mixed with said first fluid hardens into said tissue adhesive;
mixing means for thoroughly mixing said first and second fluids within said mixing area;
atomizing means for atomizing said thoroughly mixed first and second fluids by pressurized ejection of said fluids from said mixing area; and
locking means for securely locking said mixing means and said atomizing means to said first fluid providing means and said second fluid providing means during pressurization of said first and second fluids,
whereby said apparatus for applying a tissue adhesive and productive covering remains safely locked together as an integral unit even should said first and second fluids become coagulated into a solid mass within said means for mixing and atomizing.
19. The apparatus of claim 18 wherein said means for providing said first and second fluid comprises a first and second syringe respectively for holding said first and second fluids and a corresponding first and second plunger for forcing said first and second fluids from said first and second syringes respectively, a manifold having first and second corresponding component channels therethrough and first and second input connections respectively communicating with said first and second component channels, said first and second component channels terminating at corresponding exit channels adjacent to each other on opposing ends of said manifold; and
wherein said means for thoroughly mixing and atomizing said first and second fluids comprises a discharge assembly coupled to said opposing end of said manifold and receiving fluid from both said exit channels said discharge assembly from mixing fluid from both the said exit channels and delivering said mixed fluid in a spray, said discharge assembly having a first and second passage there through communicating with said exit channels from said manifold for carrying fluid from said first and second component channels in corresponding first and second passages within said discharge assembly while maintaining said first and second fluids separated from each other, said discharge assembly having a mixing space defined therein to receive separate flows from said passages, said discharge assembly further comprising mixing means disposed within said mixing space to thoroughly mix said first and second fluids for a first time within said mixing space and to immediately thereafter atomize said thoroughly mixed said first and second fluids in a spray discharged from said discharge assembly; and
wherein said locking means comprises a Luer lock coupling said manifold to said first and second syringes and a Luer lock coupling said discharge assembly to said manifold, so that even though said first and second fluids may coagulate within said discharge assembly, exertion of pressure on said first and second fluids from said first and second plunger will not cause said biological syringe system to decouple at any component part.
Description

This is a continuation-in-part of U.S. Ser. No. 07/418,707 filed Oct. 3, 1989 now U.S. Pat. No. 4,978,336, which is a continuation of U.S. Ser. No. 07/102,543 filed Sep. 29, 1987, now abandoned.

FIELD OF THE INVENTION

This invention is directed to a biological syringe system wherein two syringes separately deliver proteins which form a tissue adhesive, and wherein a manifold locks onto the syringes and a needle locks onto the manifold to deliver the mixed proteins to promote coagulation and healing.

BACKGROUND OF THE INVENTION

A biological tissue adhesive is formed when a water solution containing blood factor XIII and fibrinogen is mixed with a water solution containing thrombin. The rate at which the adhesive sets or hardens principally depends upon the thrombin concentration. The mixture is applied to the laceration site which is to be adhered or protected. Previous methods of application included applying one solution to the site of adhesion and then applying the other solution thereto. The disadvantage of this method is that inadequate mixing occurs at the site to result in setting of the adhesive at the interface between the two solutions, without good adhesion to the adjacent biological surfaces.

Another method of application comprises the premixing of the two solutions in a mixing vessel, whereupon it is drawn into a syringe and then applied to the site to be adhered. This method requires promptness of application since the setting of the adhesive starts when the two solutions are combined. The time from mixing to the time of application to the site must be quite short, and depends upon the concentration of the thrombin solution.

In another method of application, two syringes are clamped together and the output cones are inserted into a Y-piece. When the mixing occurs in the Y-piece, the adhesive setting also occurs therein to plug it up. When the mixing occurs in the needle connected onto the Y-piece, plug-up of the needle causes buildup of pressure in the Y-piece so that the needle may be separated and injected into the field, possibly into the patient. Thus, there is need for a biological syringe system wherein the needle and other parts cannot become inadvertently detached so that no parts are ejected.

BRIEF SUMMARY OF THE INVENTION

The invention is a biological syringe system for delivering a first and second fluid in a mixed composition comprising a manifold. The manifold has first and second component channels therethrough and first and second input connections respectively communicating with the first and second component channels. The first and second component channels terminate in exit channels adjacent to each other on an opposing end of the manifold. A discharge assembly is coupled to the opposing end of the manifold and receives fluid from both of the exit channels. The discharge assembly is used for mixing fluid from both of the exit channels and delivering the mixed fluid in a spray. The discharge assembly has a first and second passage therethrough communicating with the exit channels from the manifold for carrying fluid from the first and second component channels in corresponding first and second passages within the discharge assembly while maintaining the first and second fluids separated from each other. The discharge assembly has a mixing space defined therein to receive separate flows from the passages. The discharge assembly further comprises a mixing mechanism disposed within the mixing space to thoroughly mix the first and second fluids for the first time within the mixing space and to immediately thereafter atomize the thoroughly mixed first and second fluids in a spray discharged from the discharge assembly.

The mechanism for thoroughly mixing and atomizing the first and second fluid into a spray comprises a shaped spray nozzle having a spray outlet defined therein. The shaped spray nozzle is disposed within the mixing space.

The first and second passages have outlet ends. The discharge assembly comprises a solid cylindrical body disposed within the mixing space. The solid cylindrical body having a first end surface adjacent outlet ends of first and second passage in the discharge assembly. The first and second fluids exit the outlet ends of the passages and flow into a cylindrical annular space between the nozzle disposed in the mixing space and the cylindrical body disposed in the mixing space. The first and second fluids mix for the first time within the cylindrical annular space and flow to a portion of the mixing space adjacent an opposing end of the solid cylindrical body opposite the spray outlet. The mixed first and second fluids then are expressed through the spray outlet as atomized spray particles.

The mechanism swirls the first and second fluids together in the mixing space. The mechanism comprises a plurality of wedged shaped surfaces azimuthally disposed about the spray outlet. The wedged shaped surfaces are inclined in an azimuthal direction relative to the spray outlet to impel an azimuthal flow to the first and second fluids about the spray outlet.

A channel separates each of the wedged shaped surfaces. The channel in combination with an adjacent wedged shaped surface directs the flow of the first and second fluid in an azimuthal direction about a predetermined cylindrical space adjacent to and centered about the spray outlet.

The mechanism spirals the first and second fluids together to thoroughly mix the first and second fluids for the first time immediately prior to ejection through the spray outlet.

The invention is also a method for applying a tissue adhesive and protective covering which chemically forms and hardens as applied comprising the steps of providing a first fluid, and providing a second fluid which when mixed with the first fluid hardens into the tissue adhesive. The first and second fluids are forced from a corresponding first and second syringe into corresponding first and second passages. The first and second fluids are partially mixed together by flowing the fluids under pressure within a cylindrical annular space. The partially mixed first and second fluids are forced from the cylindrical annular space into a final mixing chamber. The first and second fluids are then thoroughly mixed in the final mixing chamber. The thoroughly mixed fluids are forced into an axial spray orifice. The thoroughly mixed first and second fluids are atomized by pressured ejection of the fluids through the spray orifice at a predetermined minimum pressure.

As a result, mixture of the first and second fluids is substantially improved. strength and hardening of the tissue adhesive substantially improved, and wherein thorough mixing occurs just prior to application in atomized form.

In the method the first and second fluids are swirled together as the first and second fluid flows from the outlet ends of the passages through the cylindrical annular space and thence radially inward to an axial spray orifice to thoroughly mix the fluids within a mixing space of predetermined limited volume followed by immediate ejection in atomized form for application and hardening.

In the step of thoroughly mixing the first and second fluids, the first and second fluids are spiralled together for the first time just prior to forcing the fluids through the spray outlet.

The invention is further characterized as a method for applying a tissue adhesive and protective covering which chemically forms and hardens as applied comprising the steps of providing a first fluid, and separately providing a second fluid which when mixed with the first fluid hardens into the tissue adhesive. The first and second fluids are maintained substantially separate as the fluids are delivered to a mixing chamber. The first and second fluids are thoroughly mixed in the mixing chamber for the first time. The thoroughly mixed first and second fluids are immediately atomized by pressured ejection of the fluids through a spray orifice at a predetermined minimum pressure. The step of thoroughly mixing is performed immediately before the step of atomizing so that substantially no reaction has occurred between the first and second fluids until after the step of atomizing.

As a result, mixture of the first and second fluids is substantially improved, strength and hardening of the tissue adhesive substantially improved, and wherein thorough mixing occurs just prior to application in atomized form.

The step of thoroughly mixing the first and second fluids comprises the step of swirling the first and second fluids together for the first time in the mixing chamber just prior to atomizing.

The step of thoroughly mixing is performed relative to the other steps of the method to minimize the time during which the first and second fluids are is are mixed together.

The method further comprises the step of uniformly applying the atomized mixture of the first and second fluids to a selected wound site.

The method further comprises the step of curing the applied mixture of the first and second fluids to form an artificial tissue surface.

The step of curing is performed to minimize the time during which curing of the artificial tissue occurs after the step of atomizing.

Turn now to the drawings wherein like elements are referenced by like numerals and wherein the invention can better be visualized.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 is an exploded perspective view of the biological syringe system of this invention.

FIG. 2 is an enlarged section through the manifold thereof, as seen generally along the line 2--2 of FIG. 1.

FIG. 3 is an end view of the manifold, as seen generally along the line 3--3 of FIG. 2.

FIG. 4 is an end view of an adhesive spray fitting, as seen generally along the line 4--4 of FIG. 2.

FIG. 5 is an end view of the manifold, as seen generally along the line 5--5 of FIG. 2.

FIG. 6 is a section through the manifold, as seen generally along the line 6--6 of FIG. 2.

FIG. 7 is an edge view of the manifold, with parts broken away and parts taken in section.

FIG. 8 is an enlarged section through the adhesive spray fitting, shown in exploded position in FIG. 2.

FIG. 9 is a longitudinal cross-sectional view of the spray nozzle of the invention.

FIG. 10 is an elevational view of the spray nozzle of FIG. 9 as seen through section lines 10--10.

FIG. 11 is an elevational view of the spray nozzle of FIG. 9 as seen through section lines 11--11.

DESCRIPTION OF THE PREFERRED EMBODIMENT

The biological syringe system of this invention is generally indicated at 10 in FIG. 1. The syringe system comprises a syringe holder 12, manifold 14 and adhesive applicator 16. The adhesive applicator 16 is generally indicated in FIG. 1 because it may be either a needle assembly 18 or a spray assembly 20. The manifold 14 is shown in more detail in FIGS. 2, 5, 6 and 7. The needle assembly is shown in more detail in FIG. 2, and the spray assembly is shown in more detail in FIGS. 2, 4 and 8.

The syringe holder 12, as seen in FIG. 1, has a channel-shaped body 22 which is open on the bottom, as seen in FIG. 1, to detachably receive two syringes 24 and 26. Cap 28 engages the plungers of both syringes so that the plungers are depressed at the same time and speed. Flanges 30 and 32 permit one-handed grasp of the syringe holder, in the fingers so that the user's thumb can depress the syringe plungers together. Syringes 24 and 26 are respectively fitted at their forward ends with lock fittings 34 and 36. These lock fittings are suitable to detachably lock together with companion fittings on manifold 14. Lock fitting 36 is shown in dashed lines in FIG. 2.

Manifold 14 is configured to detachably lock to the syringes and bring the output streams thereof close together. Manifold 14 is in the form of a conical ellipsoid which has lock fittings 38 and 40 at its right end. These lock fittings respectively have conical seal joints 42 and 44 thereon to receive the conical nose on their respective syringes and seal with respect thereto. Lock fittings 38 and 40, see FIG. 5, each have a pair of ears extending from the otherwise generally cylindrical exterior surface. Ears 46 and 48 are shown with respect to fitting 38. The nose of the syringe has exterior of its conical nose a cylindrical sleeve which extends over the ears 46 and 48 and has inclined flanges which engage under the ears 46 and 48 so that when inserted, a quarter turn locks the fitting together. The structure of the nose of the syringe will be described in more detail with respect to the small end of the manifold.

Component channels 50 and 52 extend separately through the manifold from the conical recesses 42 and 44 which receive the noses of the syringes to the right end of the manifold, as seen in FIG. 2. At the right end, they form separate exit channels 54 and 56 in the truncated conical forward nose 58 of the manifold. The conical nose is the same size as the conical cone on each syringe. A collar surrounds the conical nose, but the collar is interrupted to form collar segments 60 and 62, particularly see FIG. 3. The respective collar segments 60 and 62 carry flanges 64 and 66 which have an angular inner surface in the axial direction towards the larger end of the cone. The collar segments and flanges are sized so that the ears 68 and 70 on spray assembly 20, see FIG. 4, and the corresponding ears on needle 18, with ear 72 shown in FIG. 2, fit between the collar segment when ears are correctly oriented and lock behind the collar segments when the spray assembly or needle assembly is rotated a quarter turn in the clockwise direction, as looking axially towards the larger end of the conical nose.

Needle assembly 18 is configured to receive the conical nose 58 and have its ears, including ear 72, pass between the flanges 64 and 66, and upon rotation, the ears lock behind the flanges to hold the needle assembly in place. The needle assembly has a large enough interior passage to receive outflow from both exit channels 54 and 56, and this outflow passes through needle 74 and is mixed therein so that at the needle tip, mixed adhesive is delivered. FIG. 7 shows the collar segment 62 broken away to expose flange 66 and show its angular locking surface 78.

Rather than delivering the mixed adhesive by needle, sometimes it is desirable to spray the mixed adhesive on a surface. This is achieved by spray assembly 20 which has a body 76. The body 76 has a conical interior surface 78, seen in FIG. 2, which meets and seals with the conical nose 58, as shown in FIG. 8. As seen in FIG. 4, ears 68 and 70 are formed on the body and are sized to pass between the collar segments 60 and 62, as previously described, and upon rotation of the body 76 locked behind the flanges 64 and 66. Spray assembly body 76 has separate passages 80 and 82 which respectively align with channels 54 and 56 when the spray assembly body is locked in place, as shown in FIG. 8. The locking structure aligns the passages with the channel to assure passage continuity. The passages 80 and 82 open into space 84 where the fluids are mixed. The space 84 is covered by spray nozzle 86 which has a spray outlet 88. The mixed fluid sprays out of outlet 88 to be applied to the selected surface.

It is critical that the needle assembly or the spray assembly, whichever is selected, be detachably locked to the manifold. It must be detachable so that it may be changed, and locked on so that it cannot become inadvertently driven off. For example, after one use of the biological syringe system with the needle assembly in place, the mixed fluid remains within the needle 74. If the system is returned to use before the tissue adhesive sets up within the needle, it can be reused, but if the adhesive sets up in the needle, the needle must be changed. In the interim condition, if the user attempts to use it and builds up pressure against the plugged-up or almost plugged-up needle, the needle assembly can be ejected. Such is undesirable. Therefore, the needle locking system onto the manifold is critical. It is also critical to lock the spray assembly in place, and it is selected because the biological adhesive also mixes within the spray assembly. Ejection of the spray assembly is not as dangerous, but a loose piece in an operating field is to be avoided.

The locking of the manifold onto the syringes maintains the conical seal so that the biological fluid cannot escape. In the previous condition of plug-up of the needle assembly or spray assembly, actuation of the syringe plungers builds up pressure and could drive the manifold, at least loose and possibly separate from the syringes. When loose, biological fluid escapes, to the detriment of the field, and if the manifold comes loose, it is also a detriment to the field.

The spraying mechanism of the invention is illustrated in FIGS. 9-11 where spray nozzle 86 is depicted in greater detail. Turning to FIG. 9, the spray nozzle generally denoted by reference numeral 86, is comprised of a generally hollow cylindrical body or cup 100. Body 100 has a circumferential rib 102 defined on its exterior surface which provides for a degree of locking engagement when nozzle 86 is disposed within mixing space 84 as depicted in FIG. 8. The right circumferential end of body 100 as seen in FIG. 9 is radially reduced on both of its outside and inside surfaces to form a tapered edge 104 arranged and configured to fit within a corresponding or conforming surface defined within body 76 of the discharge assembly. The left end of body 100 as shown in FIG. 9 is depicted in elevational view in FIG. 11 and provides a simple flat surface within axially centered spray outlet 88 which is approximately 0.020 inch in diameter.

The interior structure of body 100 is characterized by three inclined symmetrical disposed surfaces 106, best depicted in the elevational view of FIG. 10, but also depicted in cross-sectional view in FIG. 9.

Turning to FIG. 10, the interior structure of spray nozzle 86 is characterized by axial spray outlet 88. A small cylindrical final mixing space 108 is axially disposed about the central axis 110 of the spray nozzle 86 and behind or to the right of spray outlet 88 as depicted in FIG. 9. The diameter of final mixing space 108 is approximately 0.065 inch. Adjacent and symmetrically surrounding final mixing space 108 are three inclined wedged surfaces 106 best depicted in FIG. 10. Each surface 106 is inclined beginning with a high point or thickened portion at region 112 and thereafter sloping downwardly in the depiction of FIG. 10 or, to the left in the depiction of FIG. 9, to a low or thinned portion 114. In the illustrated embodiment, the dimension of the thick or high portion 112 is approximately 0.030 inch with the thin portion 114 approaching or merging into the basal level of surface 116 best depicted in FIG. 9.

Each inclined surface 106 is separated by a channel 118 which is generally coplanar with surface 116. As depicted in FIG. 10, the angled sides 120 of each wedge 106 forms an angle 122 of approximately 15 degrees relative to a radius of spray nozzle 86.

Body 76 of the discharge assembly includes a solid cylindrical extension 77 best depicted in FIG. 2 which extends into the mixing space 84 and is axially aligned with longitudinal axis 110 of spray nozzle 86. Therefore, nozzle 86 and cylindrical portion 77 form a small annular cylindrical space 79 into which the two fluids from passages 54 and 80 on one hand, and 56 and 82 on the other, flow as best depicted in FIG. 8. The two fluids mix only to a limited degree in annular space 79 along the interface between the two streams as the streams spread into the two longitudinal halves of the cylindrical annular space 79. No substantial mixing occurs until the fluids reach mixing space 84 which is a disk-shaped space between nozzle 76 and cylinder 77 which is approximately 0.110-0.115 inch in height and 0.070-080 inch in diameter. Therefore, cylindrical annular space 79 can be visualized as a cylindrical shell approximately 0.020-0.030 inch in thickness, approximately 0.110-0.115 inch in height and approximately 0.132 inch in outer diameter. Space 79 communicates with mixing space 84 which can be visualized as a disk-shaped space approximately) 0.040 inch in height and 0.132 inch in diameter.

At this point, the fluid of each half impinges upon the uppermost or thick portion 112 of surfaces 106 defined on the internal structure of nozzle 76. The fluid is then given a rotary motion as it flows from the high point 112 of each wedge surface 106 to low point 114. Substantial mixing occurs during this portion of the fluid's travel.

Once the fluid reaches low point 114 of each surface 106 it is delivered to the adjacent channel 118. The fluid flow then changes abruptly due to the high wall presented by surface 120 and is directed radially inward along channel 118.

The flow exits channel 118 into final mixing space 108 in a generally tangential direction with respect to longitudinal axis 110. The mixed fluid becomes even more thoroughly mixed as it is swirled or rotated rapidly in a clockwise motion as shown in FIG. 10 within final mixing space 108. The mixed fluid tends to flow from the outer periphery of cylindrical mixing space 108 towards spray orifice 88 where it is ejected under pressure.

The ejected fluid continues its rotary motion even after being ejected, which assists in atomizing the mixed fluids to provide a more thoroughly distributed and homogeneous application across the area of the wound.

This invention has been disclosed in its most preferred embodiment, and it is clear that it is susceptible to numerous modifications and embodiments within the ability of those skilled in the art and without the exercise of the inventive faculty. Accordingly, the scope of this invention is defined by the scope of the following claims.

Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US2158593 *Apr 14, 1937May 16, 1939William Scrimgeour Engineer AnHypodermic syringe
US3179107 *Nov 21, 1962Apr 20, 1965Becton Dickinson CoHypodermic unit with an improved mounting for a replaceable needle assembly
US4040420 *Apr 22, 1976Aug 9, 1977General DynamicsPackaging and dispensing kit
US4109653 *Feb 22, 1977Aug 29, 1978George KozamSuccessive delivery multiple barrel syringe
US4359049 *Mar 23, 1981Nov 16, 1982Immuno Aktiengesellschaft Fur Chemisch-Medizinische ProdukteApparatus for applying a tissue adhesive on the basis of human or animal proteins
US4629455 *Feb 8, 1985Dec 16, 1986Terumo Kabushiki KaishaMedical instrument
US4631055 *Feb 26, 1985Dec 23, 1986Immuno Aktiengesellschaft Fur Chemisch-Medizinische ProdukteDisposable syringe bodies, joining pieces; human or animal proteins
US4735616 *Jun 17, 1986Apr 5, 1988Immuno Aktiengesellschaft Fur Chemisch-Medizinische ProdukteArrangement for applying a tissue adhesive
US4743229 *Sep 29, 1986May 10, 1988Collagen CorporationBone implants
US4842581 *Sep 11, 1987Jun 27, 1989Davis Richard CMedical lavage apparatus
US4874368 *Jul 25, 1988Oct 17, 1989Micromedics, Inc.Fibrin glue delivery system
US4978336 *Oct 3, 1989Dec 18, 1990Hemaedics, Inc.Biological syringe system
US4979942 *Oct 16, 1989Dec 25, 1990Johnson & Johnson Medical, Inc.Two component syringe delivery system
US5049135 *Sep 18, 1990Sep 17, 1991Code Blue Medical CorporationMedical lavage apparatus
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US5290259 *Feb 18, 1993Mar 1, 1994Ultradent Products, Inc.Double syringe delivery system
US5318524 *Mar 2, 1992Jun 7, 1994Cryolife, Inc.Fibrin sealant delivery kit
US5322510 *Nov 17, 1990Jun 21, 1994Andreas LindnerInjection apparatus
US5368563 *Nov 8, 1993Nov 29, 1994Micromedics, Inc.Sprayer assembly for physiologic glue
US5383906 *May 12, 1993Jan 24, 1995Burchett; Mark T.Nursing bottle with medication dispenser
US5464396 *Sep 22, 1994Nov 7, 1995Immuno AgSyringe assembly for the storage and application of a biological multi-component material
US5474540 *Mar 25, 1994Dec 12, 1995Micromedics, Inc.Fluid separation control attachment for physiologic glue applicator
US5478323 *Nov 2, 1994Dec 26, 1995Eli Lilly And CompanyMedication dispensing device
US5487750 *Sep 29, 1994Jan 30, 1996Burchett; Mark T.Nursing bottle with medication dispenser
US5505704 *Jun 1, 1995Apr 9, 1996Eli Lilly And CompanyManifold medication injection apparatus and method
US5542760 *Sep 26, 1995Aug 6, 1996Becton Dickinson And CompanySyringe filler for mixing insulins
US5582596 *Sep 24, 1993Dec 10, 1996Juridical Foundation The Chemo-Sero-Therapeutic Research InstituteApplicator for applying a biocompatible adhesive
US5584815 *Apr 19, 1995Dec 17, 1996Eli Lilly And CompanyMulti-cartridge medication injection device
US5605255 *Jun 26, 1995Feb 25, 1997Behringwerke AktiengesellschaftApparatus for spraying a mixture of two components
US5665067 *Feb 24, 1995Sep 9, 1997Immuno AktiengesellschaftApparatus for applying a multiple-component tissue adhesive
US5759171 *Sep 27, 1996Jun 2, 1998Thermogenesis Corp.Sprayer for fibrin glue
US5814022 *Feb 6, 1996Sep 29, 1998Plasmaseal LlcMethod and apparatus for applying tissue sealant
US5824012 *Nov 22, 1996Oct 20, 1998The Medicine Bottle Company, Inc.Nursing bottle with medication dispenser
US5887755 *Jul 21, 1997Mar 30, 1999Quantic Biomedical PartnersWound sealant preparation and application device and method
US5968018 *Oct 30, 1996Oct 19, 1999Cohesion CorporationCell separation device and in-line orifice mixer system
US5971956 *Apr 15, 1997Oct 26, 1999Biosurgical CorporationMedical suctioning apparatus and methods of use
US5975367 *Sep 27, 1996Nov 2, 1999Thermogenesis Corp.Fibrin glue line and dot dispenser
US5989215 *Jul 12, 1996Nov 23, 1999Baxter International Inc.Fibrin delivery device and method for forming fibrin on a surface
US6007515 *Oct 7, 1997Dec 28, 1999Epstein; Gordon HowardControlled action, manually operable fluid application
US6021961 *Mar 6, 1998Feb 8, 2000Flexible Products CompanyCrossover-resistant plural component mixing nozzle
US6047861 *Apr 15, 1998Apr 11, 2000Vir Engineering, Inc.Two component fluid dispenser
US6063055 *Mar 9, 1998May 16, 2000Biosurgical CorporationTurbulence mixing head for a tissue sealant applicator and spray head for same
US6096309 *Jun 17, 1998Aug 1, 2000Cohesion Technologies, Inc.Compositions containing thrombin and microfibrillar nanometer collagen, and methods for preparation and use thereof
US6132396 *Aug 3, 1998Oct 17, 2000Plasmaseal LlcApparatus for applying tissue sealant
US6274090Aug 5, 1998Aug 14, 2001Thermogenesis Corp.Apparatus and method of preparation of stable, long term thrombin from plasma and thrombin formed thereby
US6280727Nov 9, 1999Aug 28, 2001Cohesion Technologies, Inc.Hemostatic composition comprising thrombin and microfibrillar collagen in aqueous medium
US6286722 *Jan 31, 2000Sep 11, 2001Ultradent Products, Inc.Delivery tip locking collars and related systems
US6328229Dec 18, 1998Dec 11, 2001Cohesion Technologies, Inc.Low volume mixing spray head for mixing and dispensing of two reactive fluid components
US6331172Apr 14, 1997Dec 18, 2001Baxter International Inc.Applicator for dispensing measured quantities with use of controlled suction
US6394975 *May 28, 1997May 28, 2002Baxter International Inc.Method to apply compositions to a surface
US6394982Jan 31, 2000May 28, 2002United States Surgical CorporationFibrin glue applicator system
US6398761Jan 19, 2001Jun 4, 2002Ultradent Products, Inc.Double syringe barrels with ported delivery ends
US6454739 *Sep 5, 2000Sep 24, 2002Korea Greencross Corp.Fibrin sealant delivery device
US6454786Nov 14, 1997Sep 24, 2002Bristol-Myers Squibb CompanySurgical sealant; fibrin monomer liquid and a thrombin solution
US6461325 *Aug 31, 1999Oct 8, 2002Baxter International Inc.Fibrin delivery device and method for forming fibrin on a surface
US6461361Apr 30, 1999Oct 8, 2002Baxter International Inc.Gas-driven spraying of mixed sealant agents
US6471670Oct 4, 1999Oct 29, 2002Karl EnrenfelsFibrin sealant applicator system
US6472162Jun 4, 1999Oct 29, 2002Thermogenesis Corp.Obtaining blood from a patient, sequestering plasma, adding ethanol in a concentration fo 8-20% to prepare a solution containing prothrombin, converting to thrombin, filtering and applying to a patient
US6475183May 7, 1999Nov 5, 2002Baxter International Inc.Direct dual filling device for sealing agents
US6488650Dec 8, 1999Dec 3, 2002Baxter International, Inc.Direct dual filling device for sealing agents
US6537813Feb 16, 1999Mar 25, 2003Selective Genetics, Inc.Concurrent flow mixing methods and apparatuses for the preparation of gene therapy vectors and compositions prepared thereby
US6566144Mar 27, 2000May 20, 2003Atrix LaboratoriesCover plate for use in lyophilization
US6566406Dec 3, 1999May 20, 2003Incept, LlcBiocompatible crosslinked polymers
US6575940May 20, 1999Jun 10, 2003Baxter Healthcare CorporationSealant applicator and method employing impulse clearing
US6585696 *Dec 22, 2000Jul 1, 2003Baxter International, Inc.Method and apparatus for applying a medically useful multiple component material
US6605066 *Sep 15, 1999Aug 12, 2003Imedex BiomateriauxReceptacles for syringe barrels; handling; surgical adhesives; receiving and expulsion of contents; mixer also cools
US6610252Jan 22, 2002Aug 26, 2003Atrix Laboratories, Inc.System for use in lyophilization comprising delivery containers and a cover plate
US6620125 *Mar 17, 2000Sep 16, 2003Baxter AktiengesellschaftMethod and device for mixing and applying components of differing viscosities
US6620405 *Nov 1, 2001Sep 16, 20033M Innovative Properties CompanyDelivery of hydrogel compositions as a fine mist
US6626870Mar 27, 2000Sep 30, 2003Artix Laboratories, Inc.Stoppering method to maintain sterility
US6644365Apr 19, 2002Nov 11, 2003Baxter International, Inc.Tilting direct dual filling device
US6647980Jul 1, 1998Nov 18, 2003Gizurarson SveinbjoernMethod for administration of active substances to the olfactory region
US6689148Nov 21, 2001Feb 10, 2004Incept LlcMethods and apparatus for intraluminal deposition of hydrogels
US6723067Jul 26, 2001Apr 20, 2004David H. NielsonApparatus for delivering aerosolized fibrin endoscopically to a wound
US6733480Mar 14, 2002May 11, 2004Tyco Healthcare Group LpDeclogging multilumen discharge assembly
US6764467Dec 16, 1998Jul 20, 2004United States Surgical CorporationFibrin mixture and dispenser assembly
US6783514Jan 31, 1997Aug 31, 2004United States Surgical CorporationFibrin sealant applicator
US6840921Jan 10, 2003Jan 11, 2005Timothy D. HaiderApparatus and methods for simultaneously administering two or more medications to a patient
US6860870Dec 21, 2001Mar 1, 2005Focal, Inc.Self-cleaning fluid delivery device for medical applications
US6884232Oct 31, 2003Apr 26, 2005Baxter International Inc.Laparoscopic spray device and method of use
US6887974Feb 5, 2002May 3, 2005Incept LlcFor preparing protein concentrates (fibrinogens rich compositions) from blood contacted with denaturant hydrogel; drug delivery
US6921381 *Oct 5, 2001Jul 26, 2005Baxter International Inc.Laparoscopic spray device and method of use
US6926695Feb 27, 2003Aug 9, 2005Baxter International Inc.Sealant applicator and method employing impulse clearing
US6936033Aug 5, 2002Aug 30, 2005Medtronic, Inc.Multiple ratio fluid dispenser
US6972005 *Nov 7, 2002Dec 6, 2005Boehm Jr Frank HDual chamber syringe and dual lumen needle
US7018357Feb 27, 2002Mar 28, 2006Tyco Healthcare Group LpExternal mixer assembly
US7025755May 31, 2002Apr 11, 2006Baxter International Inc.Medical suctioning apparatus and methods of use
US7037289Sep 12, 2001May 2, 20063M Innovative Properties CompanyApparatus and methods for dispensing an adhesive tissue sealant
US7044402 *Oct 27, 2003May 16, 2006Finn Clifford JMulti-component fluid mix ratio check nozzle and kit
US7056722Nov 10, 2000Jun 6, 2006Thermogenesis Corp.Apparatus and method of preparation of stable, long term thrombin from plasma and thrombin formed thereby
US7057019Feb 11, 2003Jun 6, 2006Incept LlcCrosslinked albumin hydrogels
US7077339Feb 3, 2003Jul 18, 2006Biomet, Inc.Spray applicator
US7081103Nov 4, 2002Jul 25, 2006Baxter International Inc.Direct dual filling device for sealing agents
US7135027Oct 4, 2002Nov 14, 2006Baxter International, Inc.Devices and methods for mixing and extruding medically useful compositions
US7156835Feb 5, 2002Jan 2, 2007Baxter International Inc.Method of applying composition to a surface
US7169547May 15, 2001Jan 30, 2007New York Blood Center, Inc.Product from a high concentration of white blood cells with high cell viability; white blood cells are sequestered from the whole blood by preventing coagulation, separating the blood into two components, one rich in white blood cells; centrifugation, sequestering, then freezing
US7175336Jan 26, 2001Feb 13, 2007Depuy Acromed, Inc.Graft delivery system
US7207969Dec 2, 2002Apr 24, 2007Baxter International Inc.Direct dual filling device for sealing agents
US7211651Nov 13, 2002May 1, 2007Incept LlcProteinaceous gels having visualization agents and methods of use thereof
US7217254Sep 20, 2002May 15, 2007Genzyme CorporationMulti-pressure biocompatible agent delivery device and method
US7220270Jan 13, 2004May 22, 2007Incept LlcMethods and apparatus for intraluminal deposition of hydrogels
US7322956Jul 14, 2004Jan 29, 2008Straumann Holding, AbSystem and method for mixing at least four components
US7413652Apr 26, 2005Aug 19, 2008Arteriocyte Medical Systems, Inc.Method for the production of a blood component composition
US7468049Jun 14, 2005Dec 23, 2008Rieke CorporationDual syringe adapter
US7490738Oct 1, 2004Feb 17, 2009Angiotech Pharmaceuticals (Us), Inc.Mixing and dispensing fluid components of a multicomponent composition
US7597882Apr 24, 2007Oct 6, 2009Incept Llcprecursor containing a biocompatible liquid crosslinker polyethylene glycol with at least three activated acid functional groups that are strong electrophiles selected from succinimide, succinimidee ester, N-hydroxysuccinimide ester and maleimide; a ; covalently crosslink proteins; biomaterial; sealant
US7604626Jun 24, 2004Oct 20, 2009Arteriocyte Medical Systems, Inc.Multiple ratio fluid dispenser
US7605232Mar 20, 2007Oct 20, 2009Incept LlcHydrogels for protein concentration
US7618937Nov 16, 2005Nov 17, 2009Northwestern UniversityMacromolecular antifouling chimeric compositions or coatings comprising peptide or polypeptide anchor moiety or component coupled to peptoid or polypeptoid moiety or component; inhibits protein adsorption or cell fouling of surfaces onto which composition is coated; medical devices; inhibits biofouling
US7622533Aug 6, 2007Nov 24, 2009Nerites CorporationPolymeric compounds comprising dihydroxyphenyl derivatives(DHPD) or polymers modified with DHPD, with desired surface active effects; polymer backbone has structural or performance features that can be tailored to control physical properties of DHPD, allowing use for tissue adhesives or sealants
US7635343Jan 27, 2006Dec 22, 2009Arteriocyte Medical Systems, Inc.Fluid dispenser
US7641075Aug 19, 2008Jan 5, 2010Angiotech Pharmaceuticals (Us), Inc.Mixing and dispensing fluid components of a multicomponent composition
US7732539Feb 16, 2007Jun 8, 2010National Science FoundationAmidating an anionically polymerized block copolymer of methyl methacrylate-methacrylic acid-methyl methacrylate, especially a hydrolyzed methyl methacrylate-tert-butyl methacrylate-methyl methacrylate block polymer with 3( 3,4-dihydroxyphenyl)alanine ; bioadhesives
US7766900Sep 8, 2005Aug 3, 2010Biomet Manufacturing Corp.Method and apparatus for application of a fluid
US7766919Nov 2, 2006Aug 3, 2010Baxter International Inc.Devices for mixing and extruding medically useful compositions
US7776063Dec 21, 2007Aug 17, 2010Incept LlcIn situ materials formation
US7858679Jul 11, 2005Dec 28, 2010Northwestern UniversityPolymeric compositions and related methods of use
US7882860 *Mar 25, 2009Feb 8, 2011Spitz Gregory ASyringe filling apparatus
US7883501Aug 10, 2009Feb 8, 2011Arteriocyte Medical Systems, Inc.Multiple ratio fluid dispenser
US7914541Apr 13, 2007Mar 29, 2011Incept, LlcIn situ materials formation
US7943703Feb 27, 2009May 17, 2011Northwestern UniversityModified acrylic block copolymers for hydrogels and pressure sensitive wet adhesives
US8003705May 29, 2008Aug 23, 2011Incept LlcBiocompatible hydrogels made with small molecule precursors
US8030413Nov 23, 2009Oct 4, 2011Knc Ner Acquisition Sub, Inc.Biomimetic compounds and synthetic methods therefor
US8033483Apr 22, 2009Oct 11, 2011Confluent Surgical Inc.Silicone spray tip
US8067028Jul 1, 2008Nov 29, 2011Confluent Surgical Inc.Drug delivery device
US8088099Nov 23, 2009Jan 3, 2012Arteriocyte Medical Systems, Inc.Fluid dispenser
US8124075 *Jul 14, 2005Feb 28, 2012Spinal Restoration, Inc.treating a human spinal disc with defect by injecting into the disc a mixture comprises supplement drug and autologous fibrinogen and a snake venom to change fibrinogen to fibrin biosealants
US8182769Apr 4, 2008May 22, 2012Biomet Biologics, LlcClean transportation system
US8210453Sep 8, 2009Jul 3, 2012Confluent Surgical, Inc.Spray applicator
US8308340Nov 22, 2005Nov 13, 2012Smith & Nephew, Inc.Composite mixer
US8323262 *Jul 8, 2009Dec 4, 2012Hyperbranch Medical Technology, Inc.Self-contained medical applicators for multiple component formulations, and methods of use thereof
US8383092Sep 28, 2009Feb 26, 2013Knc Ner Acquisition Sub, Inc.Bioadhesive constructs
US8387899Sep 28, 2011Mar 5, 2013Confluent Surgical, Inc.Silicone spray tip
US8394072Oct 5, 2009Mar 12, 2013Spinal Restoration, Inc.Injection of fibrin sealant including an anesthetic in spinal applications
US8403895Oct 5, 2009Mar 26, 2013Spinal Restoration, Inc.Injection of fibrin sealant including an anesthetic in spinal applications
US8408480Oct 16, 2009Apr 2, 2013Confluent Surgical, Inc.Self-cleaning spray tip
US8444620Jul 8, 2010May 21, 2013Biomet Biologics, LlcMethod and apparatus for application of a fluid
US8469233Apr 16, 2009Jun 25, 2013Kuros Biosurgery AgDispensing device, kit containing the device, and method of operating the device
US8512740Mar 26, 2008Aug 20, 2013Baxter International Inc.Fibrin foam and process for making
US8518272Apr 4, 2008Aug 27, 2013Biomet Biologics, LlcSterile blood separating system
US8518440Dec 21, 2010Aug 27, 2013Confluent Surgical, Inc.Biodegradable osmotic pump implant for drug delivery
US8535705Nov 16, 2007Sep 17, 2013Incept, LlcIn situ crosslinking of biocompatible condensation polymers from small nontoxic precursors; vascular grafts, controlled release drug delivery, medical device coatings, wound dressings and surgical sealants
US8557535Sep 9, 2009Oct 15, 2013Incept LlcMethods for preparation of platelet rich plasma
US8563117Aug 6, 2007Oct 22, 2013Phillip B. MessersmithBiomimetic modular adhesive complex: materials, methods and applications therefore
US8575276Sep 26, 2011Nov 5, 2013Knc Ner Acquisition Sub, Inc.Biomimetic compounds and synthetic methods therefor
US8591929May 24, 2011Nov 26, 2013Covidien LpHydrogel implants with varying degrees of crosslinking
US8591950May 24, 2011Nov 26, 2013Covidien LpHydrogel implants with varying degrees of crosslinking
US8616468Jun 11, 2012Dec 31, 2013Covidien LpSpray applicator
US8641661Jan 4, 2011Feb 4, 2014Baxter International Inc.Mixing system, kit and mixer adapter
US8672237Jun 25, 2010Mar 18, 2014Baxter International Inc.Device for mixing and dispensing of two-component reactive surgical sealant
US8673286Apr 8, 2008Mar 18, 2014Northwestern UniversityDOPA-functionalized, branched, poly(aklylene oxide) adhesives
US8697111May 12, 2010Apr 15, 2014Covidien LpOsteochondral implant comprising osseous phase and chondral phase
US8734824May 24, 2011May 27, 2014Covidien LLPHydrogel implants with varying degrees of crosslinking
US8734930Aug 31, 2011May 27, 2014Covidien LpHydrogel implants with varying degrees of crosslinking
US8753670Mar 26, 2008Jun 17, 2014Baxter International Inc.Fibrin foam and process
US8754564Aug 31, 2011Jun 17, 2014Covidien LpHydrogel implants with varying degrees of crosslinking
US8815793Feb 28, 2005Aug 26, 2014Northwestern UniversityPolymeric compositions and related methods of use
US20090230214 *Apr 23, 2007Sep 17, 2009Medmix System AgDispensing Device with a Spray Assembly
US20120292343 *May 15, 2012Nov 22, 2012Illinois Tool Works Inc.Modular manifold adhesive gun
CN100515350CDec 7, 2004Jul 22, 2009株式会社中西Biopolymer powder gelation jetting apparatus
EP0880372A1 *Feb 3, 1997Dec 2, 1998Plasmaseal CorporationMethod and apparatus for applying tissue sealant
EP0951311A1 *Nov 14, 1997Oct 27, 1999Bristol-Myers Squibb CompanyDevices and methods for applying a mixture of two or more liquid components to form a biomaterial
EP1079889A1 *May 3, 1999Mar 7, 2001Baxter International Inc.Gas-driven spraying of mixed sealant agents
EP1265654A1 *Mar 16, 2001Dec 18, 2002United States Surgical, A Division Of Tyco Healthcare Group Lp;Declogging multilumen discharge assembly
EP1498073A1Jul 15, 2003Jan 19, 2005Straumann Holding AGSystem and procedure for mixing of at least four components
EP1961791A2 *Mar 22, 1996Aug 27, 2008Genzyme CorporationRedox and photoinitiator systems for priming for improved adherence of gels to substrates
EP1967220A2Feb 13, 2008Sep 10, 2008Confluent Surgical Inc.Low-swelling biocompatible hydrogels
EP2050473A1Aug 6, 2008Apr 22, 2009Confluent Surgical Inc.Drug delivery device
EP2163204A1Sep 11, 2009Mar 17, 2010Confluent Surgical Inc.Spray applicator
EP2174597A1Oct 6, 2009Apr 14, 2010GEM S.r.l.Dispenser for adhesive newtonian fluid
EP2196193A1Jul 8, 2009Jun 16, 2010Tyco Healthcare Group LPHydrogels suitable for use in polyp removal
EP2213245A1Jan 17, 2007Aug 4, 2010Baxter International Inc.Device, system and method for mixing
EP2233160A2Mar 26, 2010Sep 29, 2010Confluent Surgical Inc.Low-swelling biocompatible hydrogels
EP2233161A2Mar 26, 2010Sep 29, 2010Confluent Surgical Inc.Low-swelling biocompatible hydrogels
EP2311376A1Oct 15, 2010Apr 20, 2011Confluent Surgical Inc.Prevention of premature gelling of delivery devices for pH dependent forming materials
EP2314325A2Sep 30, 2010Apr 27, 2011Tyco Healthcare Group LPMulti-mechanism surgical compositons
EP2314326A2Oct 1, 2010Apr 27, 2011Tyco Healthcare Group LPSurgical compositions
EP2386290A2Mar 15, 2011Nov 16, 2011Confluent Surgical Inc.Modulating drug release rate by controlling the kinetics of the pH transition in hydrogels
EP2386321A2May 11, 2011Nov 16, 2011Tyco Healthcare Group LPIn Situ forming biphasic osteochondral plug
EP2389894A2May 27, 2011Nov 30, 2011Tyco Healthcare Group LPHydrogel implants with varying degrees of crosslinking
EP2389895A2May 27, 2011Nov 30, 2011Tyco Healthcare Group LPHydrogel implants with varying degrees of crosslinking
EP2389896A2May 27, 2011Nov 30, 2011Tyco Healthcare Group LPHydrogel implants with varying degrees of crosslinking
EP2389925A2May 27, 2011Nov 30, 2011Tyco Healthcare Group LPHydrogel implant with varying degrees of crosslinking
EP2389926A2May 27, 2011Nov 30, 2011Tyco Healthcare Group LPHydrogel implants with varying degrees of crosslinking
EP2397164A1Feb 13, 2008Dec 21, 2011Confluent Surgical Inc.Low-swelling biocompatible hydrogels
EP2457599A2Sep 9, 2011May 30, 2012Tyco Healthcare Group LPSurgical compositions
EP2468255A2Dec 20, 2011Jun 27, 2012Confluent Surgical, Inc.Biodegradable osmotic pump implant for drug delivery
EP2481426A1Jan 30, 2012Aug 1, 2012Confluent Surgical, Inc.Crosslinked polymers with the crosslinker as therapeutic for sustained release
WO1996014097A1 *Oct 31, 1995May 17, 1996Lilly Co EliManifold for injection apparatus
WO1996017638A1Dec 7, 1995Jun 13, 1996Squibb & Sons IncFibrin sealant applicator
WO1997020585A1Dec 6, 1996Jun 12, 1997Squibb Bristol Myers CoA method of applying a mixture of two liquid components
WO1997028834A1 *Feb 3, 1997Aug 14, 1997Richard D AntanavichMethod and apparatus for applying tissue sealant
WO1998020931A1 *Nov 14, 1997May 22, 1998Squibb Bristol Myers CoDevices and methods for applying a mixture of two or more liquid components to form a biomaterial
WO1999001229A1 *Jul 1, 1998Jan 14, 1999Gjerding PeterA method for administration of active substances to the olfactory region
WO1999040771A2 *Feb 16, 1999Aug 19, 1999Selective Genetics IncConcurrent flow mixing for preparing compositions comprising gene therapy vectors
WO1999044672A1Mar 5, 1999Sep 10, 1999Biosurgical CorpTurbulence mixing head for a tissue sealant applicator and spray head for same
WO1999044749A1 *Feb 24, 1999Sep 10, 1999Flexible Products CoCrossover-resistant plural component mixing nozzle
WO2000037178A1 *Dec 14, 1999Jun 29, 2000Cohesion Tech IncLow volume mixing spray head for mixing and dispensing of two reactive fluid components
WO2000056221A1Mar 17, 2000Sep 28, 2000Baxter AgMethod and device for mixing and applying components of differing viscosities, such as tissue adhesives
WO2001024869A1 *Oct 6, 1999Apr 12, 2001Us SurgicalFibrin sealant applicator system
WO2001062333A1 *Feb 23, 2001Aug 30, 2001Emmons CliffordAdhesive applicator
WO2001085355A2May 7, 2001Nov 15, 2001Baxter IntNon-newtonian fluid spray applicator and method
WO2002058762A2Jan 24, 2002Aug 1, 2002Depuy Acromed IncGraft delivery system
WO2003002005A1 *Jun 19, 2002Jan 9, 2003Biovitrum AbDispenser
WO2003047530A2 *Dec 4, 2002Jun 12, 2003Christopher J WoolvertonStorage-stable fibrin sealant
WO2007084919A1Jan 17, 2007Jul 26, 2007Baxter IntDevice, system and method for mixing
WO2007108768A1 *Mar 19, 2007Sep 27, 2007Doxa AbMixing and injection system for injectable biomaterials or artificial materials in orthopaedic applications
WO2008067239A2 *Nov 26, 2007Jun 5, 2008Nanotrope IncDroplet generating device and method
WO2009120433A2Feb 23, 2009Oct 1, 2009Baxter International IncFibrin foam and process for making
WO2011084965A2Jan 5, 2011Jul 14, 2011Baxter International Inc.Mixing system, kit and mixer adapter
WO2011092694A2Jan 27, 2011Aug 4, 2011Omrix Biopharmaceuticals Ltd.Method for improved fibrin sealing
WO2012087378A1 *Jun 24, 2011Jun 28, 2012Baxter Healthcare S. A.Device for mixing and dispensing of two-component reactive surgical sealant
WO2012127328A1Mar 23, 2012Sep 27, 2012Sofradim ProductionEnzymatically degradable compositions
WO2014043154A1Sep 11, 2013Mar 20, 2014Ethicon, Inc.Airless, non-clogging tip assembly and device
WO2014066616A1Oct 24, 2013May 1, 2014Baxter International Inc.Spray head for two component mixer
Classifications
U.S. Classification604/82, 604/191, 222/137, 239/398, 239/432
International ClassificationB05B1/34, A61B17/00, B05B11/00, A61M5/19, A61M5/34, A61M5/31, B05B11/02
Cooperative ClassificationA61B17/00491, A61M5/34, B05B11/0078, B05B11/02, A61B2017/00495, A61M2005/3104, B05B1/3436, A61M5/19
European ClassificationB05B11/02, A61B17/00L, B05B11/00B11, B05B1/34A3B4B, A61M5/34, A61M5/19
Legal Events
DateCodeEventDescription
Oct 21, 2004ASAssignment
Owner name: BAXTER HEALTCHARE SA, SWITZERLAND
Owner name: BAXTER INTERNATIONAL INC., ILLINOIS
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BASTER HEALTHCARE CORPORATION;REEL/FRAME:015259/0872
Effective date: 20041018
Owner name: BAXTER INTERNATIONAL INC. ONE BAXTER PARKWAY, DF3-
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BASTER HEALTHCARE CORPORATION /AR;REEL/FRAME:015259/0872
Oct 29, 2003FPAYFee payment
Year of fee payment: 12
May 19, 2000FPAYFee payment
Year of fee payment: 8
May 19, 2000SULPSurcharge for late payment
Dec 21, 1999REMIMaintenance fee reminder mailed
Nov 27, 1995FPAYFee payment
Year of fee payment: 4
Nov 16, 1993CCCertificate of correction
Dec 29, 1989ASAssignment
Owner name: HEMAEDICS, INC., CALIFORNIA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNORS:CAPOZZI, EMIL E.;COOKSTON, H. STEPHEN;REEL/FRAME:005213/0391
Effective date: 19891228